Akt Cancer Research Results
Akt, PKB-Protein kinase B: Click to Expand ⟱
| Source: HalifaxProj(inhibit) |
| Type: |
Akt1 is involved in cellular survival pathways, by inhibiting apoptotic processes; Akt2 is an important signaling molecule in the insulin signaling pathway. It is required to induce glucose transport.
Inhibitors:
-Curcumin: downregulate AKT phosphorylation and signaling.
-Resveratrol
-Quercetin: inhibit the PI3K/AKT pathway.
-Epigallocatechin Gallate (EGCG)
-Luteolin and Apigenin: inhibit AKT phosphorylation
|
Stroke, Cerebral Ischemic Stroke: Click to Expand ⟱
Ischemic stroke is also called brain ischemia and cerebral ischemia. Ischemia is the medical term for "lack of blood supply."
|
Scientific Papers found: Click to Expand⟱
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*Inflam↓, AntiCan↑, *antiOx↑, *cardioP↑, *hepatoP↑, *BBB↑, *Half-Life↝, *H2S↑, *BP↓, *neuroP↑, *cognitive↑, *neuroP↑, *ROS↓, *GutMicro↑, *LDH↓, *ROS↓, *lipid-P↓, *antiOx↑, *other↑, *PI3K↓, *Akt↓, *NF-kB↓, *NO↓, *iNOS↓, *PGE2↓, *COX2↓, *IL6↓, *TNF-α↓, *MPO↓, *eff↑, *NRF2↑, *Keap1↓, *TBARS↓, *creat↓, *LDH↓, *AST↓, *ALAT↓, *MDA↓, *SOD↑, *GSH↑, *GSTs↑, *memory↑, chemoP↑, IL8↓, Cyt‑c↑, Casp3↑, Casp8↑, Casp9↑, Casp12↑, p38↑, Fas↑, P53↑, P21↑, CHK1↓, CycB/CCNB1↓, GSH↓, ROS↑, TumCCA↑, Hif1a↓, Bcl-2↓, VEGF↓, TumCMig↓, STAT3↓, VEGFR2↓, p‑FAK↓,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
AntiTum↑, Cyt‑c↑, Smad1↑, Sepsis↓, NF-kB↓, ICAM-1↓, MCP1↓, MMP9↓, COX2↓, PGE2↓, ERK↓, p‑Akt↓, *ROS↓, *LDH↓, *hepatoP↑, *SOD↑, *Catalase↑, *GSH↑, *AST↓, *ALAT↓, *RenoP↑, *ROS↓, *α-SMA↓,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*ROS↓, *IronCh↑, *AntiAge↑, *antiOx↑, *Inflam↓, *neuroP↑, *lipid-P↓, *toxicity↓, *NOX4↓, *SOD↑, *HNE↓, *IL6↓, *TNF-α↓, *IL1β↓, *Sepsis↓, *eff↑, *GABA↝, *Aβ↓, Glycolysis↓, AntiTum↑, p‑Akt↓, TumCCA↑, angioG↓, VEGFR2↓, NF-kB↓,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*neuroP↑, *Inflam↓, *antiOx↑, *cardioP↑, *NRF2↑, *AMPK↑, *SOD↑, *Catalase↑, *GSH↑, *GPx↑, *ROS↓, *TNF-α↓, *IL6↓, *NF-kB↓, *COX2↓, *glucose↓, *TRPC1↓, *Ca+2↓, *HO-1↑, *NF-kB↓, *PPARα↝, *Hif1a↓, *JNK↓, *BP↓, *AntiDiabetic↑, *hepatoP↑, *TLR4↓, *NRF2↑, *Casp↓, *neuroP↑, *Aβ↓, *LDH↓, *MDA↓, *memory↑, *AChE↓, *eff↑, EMT↝, N-cadherin↓, E-cadherin↑, TumCCA↑, ROS↑, p‑P53↑, HO-1↑, NRF2↑, ChemoSen↑, mtDam↑, Casp3↑, Casp9↑, PARP↑, Bax:Bcl2↑, TumCG↓, cycD1/CCND1↓, cMyc↓, CDK2↓, mitResp↓, Glycolysis↓, Hif1a↓, PCNA↓, p‑GSK‐3β↓, VEGF↓, PI3K↓, Akt↓, mTOR↓, OS↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*antiOx↑, *Inflam↓, *hepatoP↑, *neuroP↑, *BioAv↓, *cardioP↑, *lipidLev↓, *RenoP↑, *TNF-α↓, *IL2↓, *PI3K↓, *Akt↓, *ROS↓, *cognitive↑, eff↑, cycD1/CCND1↓, hTERT/TERT↓, VEGF↓, p‑STAT3↓, TumMeta↓, TumCP↓, eff↑, eff↑, IL1β↓, IL6↓, NF-kB↓, ROS↑, MMP↓, Cyt‑c↑, Apoptosis↑, ER Stress↑, Ca+2↑, TET1↑, Let-7↑, Twist↓, EMT↓, TumCCA↑, Casp3↑, Casp9↑, BAX↑, HK2↓, GlucoseCon↓, lactateProd↓, Glycolysis↓, SHP1↑, N-cadherin↓, E-cadherin↑, UPR↑, PERK↑, ATF4↑, eIF2α↑, RadioS↑, NOTCH1↑, NRF2↓, BioAv↑, eff↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
adrenal, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*BioAv↑, *antiOx↑, *neuroP↑, *Inflam↓, *ROS↓, *H2O2↓, *GSH↑, *GPx↑, *GSR↑, *SOD↑, TumCG↓, PTEN↑, HGF/c-Met↓, PI3K↓, Akt↓, NF-kB↓, TumMeta↓, MMP2↓, MMP9↓, Ki-67↓, Casp3↑, MMP↓, H2O2↑, ROS↑, ChemoSen↑, *cardioP↑, *CDK2↓, *CDK4↓, *cycE/CCNE↓, *cycD1/CCND1↓, *RB1↓, *PCNA↓, *CREB↑, *GABA↑, *memory↑, *IGF-1↑, *ERK↑, TIMP1↑, BAX↑, Cyt‑c↑, Diablo↑, SOD2↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*antiOx↑, *BioAv↑, *GSH↑, *AChE↓, *BChE↓, *H2O2↓, *lipid-P↓, *SOD↑, *SOD2↑, *Catalase↑, *GPx↑, *neuroP↑, *HO-1↑, *cardioP↑, *MDA↓, *NF-kB↓, *IKKα↓, *ROS↓, *PI3K↑, *Akt↑, *hepatoP↑, P53↑, BAX↑, IGF-1R↓, Akt↓, AR↓, TumCP↓, GSH↑, SOD↑, Catalase↑, lipid-P↓, *TNF-α↓, *Ca+2↓,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*MitoP↑, *Inflam↓, *antiOx↑, *Risk↓, *Aβ↓, *p‑tau↓, *p62↓, *PARK2↑, *MMP↑, *ROS↓, *Strength↑, *CRP↓, *IL1β↓, *IL6↓, *TNF-α↓, *AMPK↑, *NF-kB↓, *MAPK↓, *p62↑, *NRF2↑, *SOD↑, *Catalase↑, *HO-1↑, *Ferroptosis↓, *lipid-P↓, *Cartilage↑, *PI3K↓, *Akt↓, *mTOR↓, *Apoptosis↓, *neuroP↑, *Bcl-2↓, *BAX↑, *Casp3↑, *ATP↑, *eff↑, *motorD↑, *NLRP3↓, *radioP↑, *BBB↑,
Showing Research Papers: 1 to 8 of 8
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 8
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Catalase↑, 1, GSH↓, 1, GSH↑, 1, H2O2↑, 1, HO-1↑, 1, lipid-P↓, 1, NRF2↓, 1, NRF2↑, 1, ROS↑, 4, SOD↑, 1, SOD2↑, 1,
Mitochondria & Bioenergetics ⓘ
mitResp↓, 1, MMP↓, 2, mtDam↑, 1,
Core Metabolism/Glycolysis ⓘ
cMyc↓, 1, GlucoseCon↓, 1, Glycolysis↓, 3, HK2↓, 1, lactateProd↓, 1,
Cell Death ⓘ
Akt↓, 3, p‑Akt↓, 2, Apoptosis↑, 1, BAX↑, 3, Bax:Bcl2↑, 1, Bcl-2↓, 1, Casp12↑, 1, Casp3↑, 4, Casp8↑, 1, Casp9↑, 3, Cyt‑c↑, 4, Diablo↑, 1, Fas↑, 1, HGF/c-Met↓, 1, hTERT/TERT↓, 1, p38↑, 1,
Protein Folding & ER Stress ⓘ
eIF2α↑, 1, ER Stress↑, 1, PERK↑, 1, UPR↑, 1,
DNA Damage & Repair ⓘ
CHK1↓, 1, P53↑, 2, p‑P53↑, 1, PARP↑, 1, PCNA↓, 1,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, CycB/CCNB1↓, 1, cycD1/CCND1↓, 2, P21↑, 1, TumCCA↑, 4,
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 1, EMT↝, 1, ERK↓, 1, p‑GSK‐3β↓, 1, IGF-1R↓, 1, Let-7↑, 1, mTOR↓, 1, NOTCH1↑, 1, PI3K↓, 2, PTEN↑, 1, SHP1↑, 1, STAT3↓, 1, p‑STAT3↓, 1, TumCG↓, 2,
Migration ⓘ
Ca+2↑, 1, E-cadherin↑, 2, p‑FAK↓, 1, Ki-67↓, 1, MMP2↓, 1, MMP9↓, 2, N-cadherin↓, 2, Smad1↑, 1, TET1↑, 1, TIMP1↑, 1, TumCMig↓, 1, TumCP↓, 2, TumMeta↓, 2, Twist↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, ATF4↑, 1, Hif1a↓, 2, VEGF↓, 3, VEGFR2↓, 2,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, ICAM-1↓, 1, IL1β↓, 1, IL6↓, 1, IL8↓, 1, MCP1↓, 1, NF-kB↓, 4, PGE2↓, 1,
Hormonal & Nuclear Receptors ⓘ
AR↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↑, 1, ChemoSen↑, 2, eff↑, 4, RadioS↑, 1,
Clinical Biomarkers ⓘ
AR↓, 1, hTERT/TERT↓, 1, IL6↓, 1, Ki-67↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, AntiTum↑, 2, chemoP↑, 1, OS↑, 1,
Infection & Microbiome ⓘ
Sepsis↓, 1,
Total Targets: 104
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 8, Catalase↑, 4, Ferroptosis↓, 1, GPx↑, 3, GSH↑, 5, GSR↑, 1, GSTs↑, 1, H2O2↓, 2, HNE↓, 1, HO-1↑, 3, Keap1↓, 1, lipid-P↓, 4, MDA↓, 3, MPO↓, 1, NOX4↓, 1, NRF2↑, 4, PARK2↑, 1, ROS↓, 10, SOD↑, 7, SOD2↑, 1, TBARS↓, 1,
Metal & Cofactor Biology ⓘ
IronCh↑, 1,
Mitochondria & Bioenergetics ⓘ
ATP↑, 1, MMP↑, 1,
Core Metabolism/Glycolysis ⓘ
ALAT↓, 2, AMPK↑, 2, CREB↑, 1, glucose↓, 1, H2S↑, 1, LDH↓, 4, lipidLev↓, 1, PPARα↝, 1,
Cell Death ⓘ
Akt↓, 3, Akt↑, 1, Apoptosis↓, 1, BAX↑, 1, Bcl-2↓, 1, Casp↓, 1, Casp3↑, 1, Ferroptosis↓, 1, iNOS↓, 1, JNK↓, 1, MAPK↓, 1,
Transcription & Epigenetics ⓘ
other↑, 1,
Autophagy & Lysosomes ⓘ
MitoP↑, 1, p62↓, 1, p62↑, 1,
DNA Damage & Repair ⓘ
PCNA↓, 1,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, CDK4↓, 1, cycD1/CCND1↓, 1, cycE/CCNE↓, 1, RB1↓, 1,
Proliferation, Differentiation & Cell State ⓘ
ERK↑, 1, IGF-1↑, 1, mTOR↓, 1, PI3K↓, 3, PI3K↑, 1,
Migration ⓘ
Ca+2↓, 2, Cartilage↑, 1, TRPC1↓, 1, α-SMA↓, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 1, NO↓, 1,
Barriers & Transport ⓘ
BBB↑, 2,
Immune & Inflammatory Signaling ⓘ
COX2↓, 2, CRP↓, 1, IKKα↓, 1, IL1β↓, 2, IL2↓, 1, IL6↓, 4, Inflam↓, 6, NF-kB↓, 5, PGE2↓, 1, TLR4↓, 1, TNF-α↓, 6,
Synaptic & Neurotransmission ⓘ
AChE↓, 2, BChE↓, 1, GABA↑, 1, GABA↝, 1, p‑tau↓, 1,
Protein Aggregation ⓘ
Aβ↓, 3, NLRP3↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↑, 2, eff↑, 4, Half-Life↝, 1,
Clinical Biomarkers ⓘ
ALAT↓, 2, AST↓, 2, BP↓, 2, creat↓, 1, CRP↓, 1, GutMicro↑, 1, IL6↓, 4, LDH↓, 4,
Functional Outcomes ⓘ
AntiAge↑, 1, AntiDiabetic↑, 1, cardioP↑, 5, cognitive↑, 2, hepatoP↑, 5, memory↑, 3, motorD↑, 1, neuroP↑, 9, radioP↑, 1, RenoP↑, 2, Risk↓, 1, Strength↑, 1, toxicity↓, 1,
Infection & Microbiome ⓘ
Sepsis↓, 1,
Total Targets: 109
Scientific Paper Hit Count for: Akt, PKB-Protein kinase B
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:36 Cells:% prod#:% Target#:4 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page